These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27821772)

  • 1. Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis.
    Yaffe D; Vergara-Jaque A; Forrest LR; Schuldiner S
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7390-E7398. PubMed ID: 27821772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport and inhibition mechanisms of human VMAT2.
    Wu D; Chen Q; Yu Z; Huang B; Zhao J; Wang Y; Su J; Zhou F; Yan R; Li N; Zhao Y; Jiang D
    Nature; 2024 Feb; 626(7998):427-434. PubMed ID: 38081299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.
    Ugolev Y; Segal T; Yaffe D; Gros Y; Schuldiner S
    J Biol Chem; 2013 Nov; 288(45):32160-32171. PubMed ID: 24062308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines.
    Wang Y; Zhang P; Chao Y; Zhu Z; Yang C; Zhou Z; Li Y; Long Y; Liu Y; Li D; Wang S; Qu Q
    Cell Res; 2024 Jan; 34(1):47-57. PubMed ID: 38163846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2.
    Pidathala S; Liao S; Dai Y; Li X; Long C; Chang CL; Zhang Z; Lee CH
    Nature; 2023 Nov; 623(7989):1086-1092. PubMed ID: 37914936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ins and outs of vesicular monoamine transporters.
    Yaffe D; Forrest LR; Schuldiner S
    J Gen Physiol; 2018 May; 150(5):671-682. PubMed ID: 29666153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural mechanisms for VMAT2 inhibition by tetrabenazine.
    Dalton MP; Cheng MH; Bahar I; Coleman JA
    Elife; 2024 Mar; 12():. PubMed ID: 38517752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter recognition by human vesicular monoamine transporter 2.
    Im D; Jormakka M; Juge N; Kishikawa JI; Kato T; Sugita Y; Noda T; Uemura T; Shiimura Y; Miyaji T; Asada H; Iwata S
    Nat Commun; 2024 Sep; 15(1):7661. PubMed ID: 39284862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2.
    Yaffe D; Radestock S; Shuster Y; Forrest LR; Schuldiner S
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):E1332-41. PubMed ID: 23530208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of residues involved in substrate recognition by a vesicular monoamine transporter.
    Merickel A; Rosandich P; Peter D; Edwards RH
    J Biol Chem; 1995 Oct; 270(43):25798-804. PubMed ID: 7592763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe.
    Gopalakrishnan A; Sievert M; Ruoho AE
    Mol Pharmacol; 2007 Dec; 72(6):1567-75. PubMed ID: 17766642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate.
    Steiner-Mordoch S; Shirvan A; Schuldiner S
    J Biol Chem; 1996 May; 271(22):13048-54. PubMed ID: 8662678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport.
    Bernstein AI; Stout KA; Miller GW
    J Neurosci Methods; 2012 Aug; 209(2):357-66. PubMed ID: 22698664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.
    Erickson JD; Eiden LE; Schafer MK; Weihe E
    J Mol Neurosci; 1995; 6(4):277-87. PubMed ID: 8860238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat.
    Shirvan A; Laskar O; Steiner-Mordoch S; Schuldiner S
    FEBS Lett; 1994 Dec; 356(1):145-50. PubMed ID: 7988710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into vesicular monoamine storage and drug interactions.
    Ye J; Chen H; Wang K; Wang Y; Ammerman A; Awasthi S; Xu J; Liu B; Li W
    Nature; 2024 May; 629(8010):235-243. PubMed ID: 38499039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites.
    Naudon L; Raisman-Vozari R; Edwards RH; Leroux-Nicollet I; Peter D; Liu Y; Costentin J
    Eur J Neurosci; 1996 Apr; 8(4):842-6. PubMed ID: 9081637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.
    Torres B; Ruoho AE
    Neuroscience; 2014 Feb; 259():194-202. PubMed ID: 24321511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels.
    Sievert MK; Hajipour AR; Ruoho AE
    Anal Biochem; 2007 Aug; 367(1):68-78. PubMed ID: 17559790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally important carboxyls in a bacterial homologue of the vesicular monoamine transporter (VMAT).
    Yaffe D; Vergara-Jaque A; Shuster Y; Listov D; Meena S; Singh SK; Forrest LR; Schuldiner S
    J Biol Chem; 2014 Dec; 289(49):34229-40. PubMed ID: 25336661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.